Xeris Biopharma Holdings Inc (XERS)

Interest Expense

$6.95M

Quarterly · Period ending: · USD

XERS logo

XERS Interest Expense

Latest reported$6.95M
XERS Quarterly Interest Expense ($0.00 → $6.95M)
High-resolution chart · PNG

XERS interest expense history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Interest Expense — Quarterly (USD)
Period endingInterest Expense (USD)
6,947,000
6,884,000
7,153,000
7,268,000
7,358,000
7,305,000
7,703,000
7,786,000
7,964,000
7,032,000
7,018,000
6,847,000
6,528,000
6,216,000
4,367,000
3,989,000
3,448,000
3,521,000
1,796,000
1,798,000
1,795,000
1,791,000
4,591,000
2,328,000
2,242,000
1,499,000
1,531,000
3,507,000
1,062,000
1,063,000
1,055,000
737,000
562,000
191,000
1,000
0
1,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.